Literature DB >> 21574153

RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank.

Umberto Nanni1, Antonella Spila, Silvia Riondino, Maria Giovanna Valente, Paolo Somma, Mauro Iacoboni, Jhessica Alessandroni, Veronica Papa, David Della-Morte, Raffaele Palmirotta, Patrizia Ferroni, Mario Roselli, Fiorella Guadagni.   

Abstract

BACKGROUND: Biospecimen quality is crucial for clinical and translational research and its loss is one of the main obstacles to experimental activities. Beside the quality of samples, preanalytical variations render the results derived from specimens of different biobanks or even within the same biobank incomparable. Specimens collected along the years should be managed with a heterogeneous life cycle. Hence, we propose to collect detailed data concerning the whole life cycle of stored samples employing radio-frequency identification (RFID) technology.?
METHODS: We describe the processing chain of blood biosamples that is operative at the biobank of IRCSS San Raffaele, Rome, Italy (BioBIM). We focus on the problem of tracing the stages following automated preanalytical processing: we collected the time stamps of all events that could affect the biological quality of the specimens by means of RFID tags and readers.?
RESULTS: We developed a pilot study on a fragment of the life cycle, namely the storage between the end of the preanalytics and the beginning of the analytics, which is usually not traced by automated tools because it typically includes manual handling. By adopting RFID devices we identified the possible critical time delays. At 1, 3 and 6 months RFID-tagged specimens cryopreserved at -80°C were successfully read.?
CONCLUSIONS: We were able to record detailed information about the storage phases and a fully documented specimen life cycle. This will allow us to promote and tune up the best practices in biobanking because i) it will be possible to classify sample features with a sharper resolution, which allows future utilization of stored material; ii) cost-effective policies can be adopted in processing, storing and selecting specimens; iii) after using each aliquot, we can study the life cycle of the specimen with a possible feedback on the procedures.

Mesh:

Year:  2011        PMID: 21574153     DOI: 10.5301/JBM.2011.8323

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  5 in total

1.  Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM).

Authors:  Raffaele Palmirotta; Piero Barbanti; Giorgia Ludovici; Gabriella Egeo; Cinzia Aurilia; Luisa Fofi; Maria Laura De Marchis; Antonella Spila; Patrizia Ferroni; David Della-Morte; Fiorella Guadagni
Journal:  Neurol Sci       Date:  2013-01-26       Impact factor: 3.307

2.  Study of the uses of Information and Communication Technologies by Pain Treatment Unit Physicians.

Authors:  Jorge Muriel Fernandez; María José Sánchez Ledesma; Manuel López Millan; María Begoña García Cenador
Journal:  J Med Syst       Date:  2017-03-27       Impact factor: 4.460

3.  Effects of preanalytic variables on circulating microRNAs in whole blood.

Authors:  Hua Zhao; Jie Shen; Qiang Hu; Warren Davis; Leonardo Medico; Dan Wang; Li Yan; Yuqing Guo; Biao Liu; Maochun Qin; Mary Nesline; Qianqian Zhu; Song Yao; Christine B Ambrosone; Song Liu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

4.  Digital pathology and image analysis augment biospecimen annotation and biobank quality assurance harmonization.

Authors:  Bih-Rong Wei; R Mark Simpson
Journal:  Clin Biochem       Date:  2013-12-18       Impact factor: 3.281

5.  Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy.

Authors:  Patrizia Ferroni; Fiorella Guadagni; Silvia Riondino; Ilaria Portarena; Sabrina Mariotti; Francesca La Farina; Giovanni Davì; Mario Roselli
Journal:  Haematologica       Date:  2014-08-01       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.